School of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang, China
School of Clinical Medical, Jiamusi University, Jiamusi, Heilongjiang, China
Balkan Med J. 2022 Jan 25;39(1):30-38. doi: 10.5152/balkanmedj.2021.21068. Epub 2021 Dec 20.
Diffuse large B-cell lymphoma is a type of B-cell non-Hodgkin lymphoma with a high incidence. About one-third of patients are resistant or eventually relapse. The prognosis for patients with relapsed/resistant diffuse large B-cell lymphoma who need salvage therapy is not optimistic.
To explore whether homebox D3 binding to lysine (K)-specific demethylase 5C promoted malignant progression of diffuse large B-cell lymphoma by decreasing p53 expression.
Cell culture study.
The mRNA and protein expression of lysine (K)-specific demethylase 5C and homebox D3 in cells were respectively detected by real-time quantitative polymerase chain reaction analysis and Western blot. Real-time quantitative polymerase chain reaction analysis and Western blot were also applied to determine the transfection effects of shRNA-KDM5C or OeHOXD3 in OCI-Ly7 cells. After transfection, the cell viability, proliferation, and apoptosis were respectively analyzed by Cell Counting Kit-8 assay, EdU staining, and acridine orange—ethidium bromide staining. The interaction between homebox D3 and lysine (K)-specific demethylase 5C promoter was verified by the dual-luciferase reporter assay and chromatin immunoprecipitation (ChIP) assay.
Lysine (K)-specific demethylase 5C mRNA expression (HBL1 2.84 ± 0.29; SUDHL4 3.53 ± 0.21; OCI-Ly8 4.06 ± 0.24; OCI-Ly7 5.03 ± 0.28 vs. GM12878 1.00 ± 0.07; all < .001) and protein expression (HBL1 1.52 ± 0.06; SUDHL4 1.77 ± 0.10; OCI-Ly8 2.34 ± 0.07; OCI-Ly7 2.78 ± 0.07 vs. GM12878 1.00 ± 0.07; all < .001) in DLBCL cells were higher than that in GM12878 cells and showed the highest in OCI-Ly7 cells. Homebox D3 mRNA (OCI-Ly7 3.85 ± 0.17 vs. GM12878 1.00 ± 0.05; < .001) and protein (OCI-Ly7 1.73 ± 0.10 vs. GM12878 1.00 ± 0.06; < .001) expression were also highly expressed in OCI-Ly7 cells. Moreover, down-regulation of lysine (K)-specific demethylase 5C suppressed the viability and proliferation and enhanced the apoptosis of OCI-Ly7 cells. Knockdown of lysine (K)-specific demethylase 5C decreased the B-cell lymphoma 2 expression while increased the expression of Bax, cleaved caspase 3, cytochrome C, p53, and p21. The transcription factor homebox D3 was confirmed to interact with the lysine (K)-specific demethylase 5C promoter. Homebox D3 overexpression could reverse the regulating effect of down-regulation of lysine (K)-specific demethylase 5C on the OCI-Ly7 cells.
Homebox D3 up-regulating lysine (K)-specific demethylase 5C promotes malignant progression of diffuse large B-cell lymphoma by decreasing p53 expression.
弥漫大 B 细胞淋巴瘤是一种具有高发病率的 B 细胞非霍奇金淋巴瘤。约三分之一的患者对治疗具有耐药性或最终复发。需要挽救性治疗的复发/难治性弥漫大 B 细胞淋巴瘤患者的预后并不乐观。
探讨同源盒 D3 与赖氨酸(K)特异性去甲基酶 5C 结合是否通过降低 p53 表达促进弥漫大 B 细胞淋巴瘤的恶性进展。
细胞培养研究。
实时定量聚合酶链反应分析和 Western blot 分别检测细胞中赖氨酸(K)特异性去甲基酶 5C 和同源盒 D3 的 mRNA 和蛋白表达。实时定量聚合酶链反应分析和 Western blot 也用于确定 OCI-Ly7 细胞中转染 shRNA-KDM5C 或 OeHOXD3 的效果。转染后,通过细胞计数试剂盒-8 分析、EdU 染色和吖啶橙-溴化乙锭染色分别分析细胞活力、增殖和凋亡。通过双荧光素酶报告基因检测和染色质免疫沉淀(ChIP)检测验证同源盒 D3 与赖氨酸(K)特异性去甲基酶 5C 启动子之间的相互作用。
赖氨酸(K)特异性去甲基酶 5C mRNA 表达(HBL1 2.84 ± 0.29;SUDHL4 3.53 ± 0.21;OCI-Ly8 4.06 ± 0.24;OCI-Ly7 5.03 ± 0.28 与 GM12878 1.00 ± 0.07;均<.001)和蛋白表达(HBL1 1.52 ± 0.06;SUDHL4 1.77 ± 0.10;OCI-Ly8 2.34 ± 0.07;OCI-Ly7 2.78 ± 0.07 与 GM12878 1.00 ± 0.07;均<.001)在 DLBCL 细胞中高于 GM12878 细胞,在 OCI-Ly7 细胞中最高。同源盒 D3 mRNA(OCI-Ly7 3.85 ± 0.17 与 GM12878 1.00 ± 0.05;<.001)和蛋白(OCI-Ly7 1.73 ± 0.10 与 GM12878 1.00 ± 0.06;<.001)在 OCI-Ly7 细胞中也高表达。此外,下调赖氨酸(K)特异性去甲基酶 5C 抑制了 OCI-Ly7 细胞的活力和增殖,并增强了其凋亡。下调赖氨酸(K)特异性去甲基酶 5C 降低了 B 细胞淋巴瘤 2 的表达,同时增加了 Bax、cleaved caspase 3、细胞色素 C、p53 和 p21 的表达。同源盒 D3 被证实与赖氨酸(K)特异性去甲基酶 5C 启动子相互作用。同源盒 D3 过表达可以逆转下调赖氨酸(K)特异性去甲基酶 5C 对 OCI-Ly7 细胞的调节作用。
同源盒 D3 上调赖氨酸(K)特异性去甲基酶 5C 通过降低 p53 表达促进弥漫大 B 细胞淋巴瘤的恶性进展。